Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
- 1 January 2015
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 27 (1), 15-26
- https://doi.org/10.1016/j.ccell.2014.12.001
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancerBritish Journal of Cancer, 2013
- EMu: probabilistic inference of mutational processes and their localization in the cancer genomeGenome Biology, 2013
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancerBritish Journal of Cancer, 2012
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersNature, 2012
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerNature, 2012
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- The Life History of 21 Breast CancersCell, 2012
- Cancer chromosomal instability: therapeutic and diagnostic challengesEMBO Reports, 2012
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer DevelopmentCell, 2011
- A small-cell lung cancer genome with complex signatures of tobacco exposureNature, 2009